Orbit Biotech

orbitbiotech.com

Estd in 2006, Orbit Biotech is a flagship biotech division of Zodiac Brand Space Pvt. Ltd. an ISO 9001:2008 certified company. The company is focussed on its research in Probiotics and the team has successfully completed many research projects funded by Department of Biotechnology (DBT), Govt. of India. Several in-house research projects aiming at developing state of the art probiotic applications are under process. The company is pioneer in training biotech students and professionals aiming at creating a skilled biotech professionals though its programs. Our aspiration is to provide biotechnology solutions by finding better methods of applications and work actively to promote collaborations between all parties in biotechnological industry in order to achieve our common goal of global competence. Our research and technology leads to the discovery of new and innovative products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy, MedTech

EUROFINS GENOMICS BLUE HERON LAUNCHES IVT MRNA SYNTHESIS SERVICE: THE FUTURE OF GENE EXPRESSION

PRNewswire | June 30, 2023

news image

Eurofins Genomics Blue Heron is thrilled to announce the launch of our cutting-edge IVT mRNA Synthesis Service. With this revolutionary service, we aim to offer a game-changing solution to the challenges of gene expression research. The new service offers a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The IVT mRNA Synthesis Service is based on the latest in vitro transcription (IVT) technology, which allows ...

Read More

RGENTA THERAPEUTICS LAUNCHES WITH $20 MILLION SEED INVESTMENT

BioSpace | April 02, 2020

news image

Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historically undruggable disease-relevant targets, announced today that it closed a $20 Million seed investment, co-led by Boehringer Ingelheim Venture Fund and Matrix Partners China. Rounding out the series seed syndicate are two additional investors, Kaitai Capital and Legend Star Fund. The company has assembled a world-class team of small-molecule drug developers and an exceptional Scientific A...

Read More

MARINE BIOTECHNOLOGY MARKET 2020

Publicist 360 | April 08, 2020

news image

IndustryGrowthInsights, 08-04-2020: The research report on the Marine Biotechnology Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data an...

Read More

MedTech

HALO LABS LAUNCHES THE AURA GT™ FOR GENE THERAPY PRODUCT QUALITY

Halo Labs | October 05, 2021

news image

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, Aura GT. Aura GT is part of the next generation in Halo Labs' popular family of instruments. Using Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM), Aura GT can distinguish aggregated capsids from contaminants, carrier proteins, and other particles that might adversely harm patients. Unique to Aura GT is...

Read More
news image

Cell and Gene Therapy, MedTech

EUROFINS GENOMICS BLUE HERON LAUNCHES IVT MRNA SYNTHESIS SERVICE: THE FUTURE OF GENE EXPRESSION

PRNewswire | June 30, 2023

Eurofins Genomics Blue Heron is thrilled to announce the launch of our cutting-edge IVT mRNA Synthesis Service. With this revolutionary service, we aim to offer a game-changing solution to the challenges of gene expression research. The new service offers a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The IVT mRNA Synthesis Service is based on the latest in vitro transcription (IVT) technology, which allows ...

Read More
news image

RGENTA THERAPEUTICS LAUNCHES WITH $20 MILLION SEED INVESTMENT

BioSpace | April 02, 2020

Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historically undruggable disease-relevant targets, announced today that it closed a $20 Million seed investment, co-led by Boehringer Ingelheim Venture Fund and Matrix Partners China. Rounding out the series seed syndicate are two additional investors, Kaitai Capital and Legend Star Fund. The company has assembled a world-class team of small-molecule drug developers and an exceptional Scientific A...

Read More
news image

MARINE BIOTECHNOLOGY MARKET 2020

Publicist 360 | April 08, 2020

IndustryGrowthInsights, 08-04-2020: The research report on the Marine Biotechnology Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data an...

Read More
news image

MedTech

HALO LABS LAUNCHES THE AURA GT™ FOR GENE THERAPY PRODUCT QUALITY

Halo Labs | October 05, 2021

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, Aura GT. Aura GT is part of the next generation in Halo Labs' popular family of instruments. Using Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM), Aura GT can distinguish aggregated capsids from contaminants, carrier proteins, and other particles that might adversely harm patients. Unique to Aura GT is...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us